Bibliografia

1. Thieme D, Hemmersbach Peter (eds). Doping in sports: biochemical principles, effects and analysis. handbook of experimental pharmacology, Volume 195. Berlin, Heidelberg: Springer, 2010.
2. Georgakopoulos C, Saugy M, Giraud S, Robinson N, Alsayrafi M. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories. Bioanalysis 2012; 4(13): 1549-63.
3. Botrè F. New and old challenges of sports drug testing. J Mass Spectrom 2008; 43: 903-7.
4. The World Anti-Doping Agency. The World Anti-Doping Code. Montreal (Canada): World Anti-Doping Agency, 2015.
5. The World Anti-Doping Agency. The World Anti-Doping Code. International Standard: The Prohibited List. Montreal (Canada): World Anti-Doping Agency, 2016.
6. Botrè F. Mass spectrometry and illicit drug testing: analytical challenges of the antidoping laboratories. Expert Rev Proteomics 2008; 5: 535-9.
7. Thevis M. Mass spectrometry in sports drug testing: characterization of prohibited substances and doping control analytical assays. Hoboken (New Jersey, USA): John Wiley & Sons Inc., 2010.
8. Georgakopoulos K, Alsayrafi M (eds). Advances and challenges in antidoping analysis. London (UK): Future Sciences, 2015.
9. Botrè F, de la Torre X, Donati F, Mazzarino M. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests. Br J Sports Med 2014; 48: 833-6.
10. Leuenberger N, Robinson N, Saugy M. Circulating miRNAs: a new generation of anti-doping biomarkers. Anal Bioanal Chem 2013; 405(30): 9617-23.
11. Donati F, Boccia F, Stampella A, de la Torre X, Botrè F. The approach of microRNA expression analysis in the detection of autologous blood transfusion in doping control. J Biol Res 2015; 88: 63-4.